• / Free eNewsletters & Magazine
  • / My Account
Home>Insulet Breaks Ground on New U.S. Manufacturing Facility

Insulet Breaks Ground on New U.S. Manufacturing Facility

Insulet Breaks Ground on New U.S. Manufacturing Facility


Insulet Breaks Ground on New U.S. Manufacturing Facility

$100 Million Investment in Massachusetts Will Provide for Hundreds of Local Manufacturing Jobs at a 350,000 Square-Foot Facility

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), will host a groundbreaking celebration today at its new, state-of-the-art manufacturing facility on a 26-acre site in Acton, Massachusetts.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170928005162/en/

The new facility represents a significant investment in Massachusetts, is expected to create hundreds of local jobs, and will provide additional manufacturing capabilities closer to Insulet’s large and growing U.S. customer base. The new U.S. manufacturing operation is also expected to drive operating efficiencies and increase productivity. The Company plans to begin production at this location in 2019.

Massachusetts Governor, Charlie Baker, will join Insulet speakers Patrick Sullivan, Chairman and Chief Executive Officer, and Shacey Petrovic, President and Chief Operating Officer, to celebrate the groundbreaking event. Other special guests include Travis McCready, Chief Executive Officer of the Massachusetts Life Sciences Center, dignitaries from the Commonwealth of Massachusetts, and members of Insulet’s loyal “Podder” (customer) community.

“We are excited to see Insulet’s continued growth in Massachusetts, including the manufacturing jobs and innovations that will come from this new Acton facility,” said Governor Charlie Baker. “Insulet has called the Commonwealth home for nearly 20 years, investing in our communities, providing jobs and developing technologies and products that better serve patients around the globe.”

“Investing in our state-of-the-art manufacturing facility allows us to increase our capacity to better support our Omnipod customers, create local jobs and further strengthen our commitment to Massachusetts,” said Patrick Sullivan, Chairman and Chief Executive Officer. “We are experiencing significant growth across our business, and this facility will help us achieve our long-term objectives. I am grateful to Governor Baker and his staff, as well as the Acton community, for supporting all of our efforts. We are committed to providing world-class service to our Podders and improving the lives of those living with diabetes.”

©2017 Morningstar Advisor. All right reserved.